Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitogen-activated protein kinase (MAPK) pathway is a highly conserved signal transduction cascade present in all eukaryotic cells. It plays a central role in converting extracellular signals into various intracellular responses, regulating essential cellular processes such as proliferation, differentiation, survival, apoptosis, gene expression, and motility. Dysregulation of this pathway is implicated in cancer, making components of the RAS–RAF–MEK–ERK axis therapeutic targets. The pathway consists of three sequentially acting kinases: MAPKKK, MAPKK, and MAPK. Major cascades include ERK1/2, JNK, p38, and ERK5, each involved in distinct cellular functions. Activation is tightly regulated and involves receptor engagement, adaptor proteins, and phosphorylation events.
Inhibition of kinase activity within the MAPK cascade
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-Activated Protein Kinase (MAPK) Pathway (None).